Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

The endorsement by WHO follows a similar update by the American Society for Colposcopy and Cervical Pathology (ASCCP) in ...

January is Cervical Health Awareness Month and Cervical Cancer Screening Month, an opportune time to share some statistics, screening tools and treatment information about the fourth most common ...

Drexel's Comprehensive Colposcopy Training Course is the expert resource in cervical and lower genital tract pathology. Participants will be exposed to a premier panel of speakers who offer the most ...

Cervical cancer screening traditionally relies on the Pap smear and HPV-DNA tests. While effective, these methods are fraught with challenges, including variability in human interpretation, false ...

today announced that the BD Onclarity™ HPV Assay has officially been added to the American Society for Colposcopy and Cervical Pathology (ASCCP) Enduring Risk-Based Management Guidelines ...

The American Society for Colposcopy and Cervical Pathology recommendation for management of an ECC positive for CIN is acknowledged within the KPNC cancer screening guidelines. Women with index ...

The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...